用天然产品准SHP2:探索基于沙宁的菌抑制剂及其治疗潜力
1Department of Biology Education, Daegu University, 201, Daegudae-ro, Gyeongsan-si 38453, Gyeongsangbuk-do, Republic of Korea.
Current issues in molecular biology
|July 23, 2025
概括
作为SHP2 (一种蛋白质氨酸酸酶) 的全抑制剂,天然氨酸具有前景,比传统药物具有更好的特异性. 这些化合物可以克服局限性并增强癌症疗法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- SHP2 (一种非受体蛋白氨酸酸酶) 调节关键细胞信号通路 (RAS/MAPK,PI3K/AKT).
- 由于突变,SHP2活动的失调驱动癌症的发展和药物耐药性.
- 现有的SHP2催化抑制剂在选择性和生物可用性方面存在局限性.
研究的目的:
- 审查以沙因为基础的化合物作为全性SHP2抑制剂的潜力.
- 探索它们的行动机制,特别是针对SHP2道现场.
- 讨论它们与传统抑制剂相比的治疗优势.
主要方法:
- 文献综述侧重于SHP2结构-功能动态.
- 对沙素结构及其对SHP2的抑制作用的分析.
- 检查沙素和SHP2道遗留物之间的相互作用.
主要成果:
- 沙胺具有作为SHP2.2的特异性,全抑制剂的潜力.
- 它们与SHP2道现场内的关键残留物相互作用.
- 沙素可以克服催化抑制剂的局限性,并在组合疗法中有用.
结论:
- 基于沙宁的全抑制剂代表了对SHP2驱动疾病的有前途的治疗策略.
- 需要进一步优化和创新方法,如PROTACs,以提高临床效用.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K


